$SNDL

SNDL Q3'26 Earnings: revenue estimate is 164.18M USD

SNDL Inc. is expected to report Q3'26 earnings on October 27, with revenue estimated at 164.18M USD and EPS at (0.01) USD. The announcement is scheduled for 9:30 AM ET.

Original reporting
Published Oct 20, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SNDL Q3'26 Earnings: revenue estimate is 164.18M USD — source image
Decision brief

The 30-second read

$SNDLNeutralLow
01

Why it matters

The preview sets expectations but does not constitute a material new event; traders may watch for the actual release.

02

Market read

Earnings preview with modest estimates; limited immediate trading relevance.

03

What to watch

Potential hidden guidance or market reaction to broader sector trends not mentioned.

Relevance 4/10Novelty 3/10Timing: pre‑market Oct 27

Background

SNDL Inc. is a U.S.-listed cannabis company that reports quarterly results on a regular schedule.

Company-level read

Ticker impact

$SNDLNeutralMedium confidence
Context

Article previews SNDL's Q3'26 earnings with revenue estimate of $164.18M and EPS of $0.01, scheduled for release Oct 27 before market open.

Expected impact

limited pressure as market anticipates modest earnings

Evidence & confidence

No actual results are released yet; only an estimate is provided, so impact is likely small and short‑term.

Market effects

Provides a data point for the cannabis sector's upcoming earnings season.

Limited to U.S. investors tracking small‑cap biotech/health stocks.

Minimal global impact.

Counterpoint

If the estimate is overly conservative, the stock could rally on a surprise beat.

Key entities

  • SNDL Inc.

    U.S.-listed cannabis producer.

Related articles

$SNDLMed

SNDL Announces 2026 Annual and Special Shareholders Meeting Results, Select Preliminary Third Quarter Results and Capital Return Initiatives

SNDL reported record Q3 2026 free cash flow of C$20M, driven by insurance unwinding and working capital. Shareholders approved directors and auditor but rejected share consolidation. The company repurchased 5.4M shares in Q3, totaling 21.8M over 12 months. SNDL plans a potential C$50M share buyback and renewing its repurchase program. It also increased its stake in U.S. cannabis operator Parallel to 92%.

$SNDLMedAI 8/10

Alberta-based retailer hit by Canadians drinking less booze, smoking less weed

SNDL Inc, an Edmonton-based liquor and cannabis retailer, reported Q2 revenue down about 4% to $235.8 million and a nearly $8 million loss. Liquor sales fell about 5% to $134.7 million and cannabis store sales slipped 1.4% to $83.2 million. Management cited weaker Canadian demand and vape production issues, and said U.S. retail expansion in Florida, Texas and Massachusetts is pending.

$SNDLMedAI 8/10

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Net revenue fell 3.7% to C$235.8M and gross profit declined 16.6% to C$56.3M. Operating loss was C$(7.8)M. Cash flow was C$(30.2)M, with free cash flow C$(6.7)M. SNDL said it had C$183.2M unrestricted cash and no debt, and repurchased 11.7M shares. It also said a restructuring of Surterra’s Parallel is expected to give it control of medical cannabis operations in coming months.

$SNDLMedAI 8/10

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

SNDL Inc. (NASDAQ: SNDL) said it completed the April 29, 2026 acquisition of assets from Surterra Holdings and affiliates via a strict foreclosure. The deal reduces about US$842 million of Parallel debt and gives SNDL indirect majority economic exposure equivalent to 66.7% of TransactionCo equity and 69.4% of debt. Acquired assets include 56 retail and 3 cultivation/manufacturing sites with about US$150 million annualized revenue.

$CIAMedAI 8/10

Small caps to watch: Earnings from EQB, Coveo, Champion Iron and more

Canada’s S&P/TSX Small Cap Index is up about 67% over 52 weeks (record 1,472.68 on May 13), while the U.S. Russell 2000 is up about 40% (record 2,932.74 on Wednesday). EQB beat Q2 revenue/adjusted EPS but credit-loss provisions rose to $45.4M; revenue was $302–4M. Coveo’s Q4 matched expectations, but FY27 SaaS growth guidance (~9.5%) was seen below forecasts. Champion Iron Q4 revenue fell to $414.5M and net income to $23.2M. SNDL said its Ontario store purchase won’t proceed; it plans to realloc